Yield10 Bioscience, Inc.
YTENQ
$0.015
$0.000.00%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 190.70% | -16.90% | -86.67% | -71.46% | -47.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 190.70% | -16.90% | -86.67% | -71.46% | -47.98% |
| Cost of Revenue | -11.73% | -9.30% | 5.64% | 8.78% | 13.99% |
| Gross Profit | 18.49% | 8.95% | -11.33% | -14.73% | -18.70% |
| SG&A Expenses | -1.99% | -5.08% | 0.05% | 0.00% | -0.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.46% | -6.54% | 4.14% | 5.76% | 8.32% |
| Operating Income | 11.07% | 6.27% | -7.18% | -8.77% | -10.49% |
| Income Before Tax | 10.02% | 5.23% | -7.79% | -8.77% | -16.51% |
| Income Tax Expenses | -- | -- | -- | 239.47% | 294.29% |
| Earnings from Continuing Operations | 10.89% | 6.22% | -6.55% | -9.43% | -17.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.89% | 6.22% | -6.55% | -9.43% | -17.31% |
| EBIT | 11.07% | 6.27% | -7.18% | -8.77% | -10.49% |
| EBITDA | 11.23% | 6.49% | -7.12% | -8.70% | -10.38% |
| EPS Basic | 60.52% | 46.10% | 24.43% | 8.19% | -11.63% |
| Normalized Basic EPS | 60.12% | 45.53% | 23.56% | 8.89% | -4.75% |
| EPS Diluted | 60.52% | 46.10% | 24.42% | 8.18% | -11.64% |
| Normalized Diluted EPS | 60.12% | 45.53% | 23.56% | 8.89% | -4.75% |
| Average Basic Shares Outstanding | 137.08% | 98.00% | 61.24% | 25.84% | 5.38% |
| Average Diluted Shares Outstanding | 137.08% | 98.00% | 61.24% | 25.84% | 5.38% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
